- Omalizumab
Drugs.com drugs.com monograph omalizumab pregnancy category B legal status routes of administration ... O 2023 S 38 molecular weight 145058.2 g mol Omalizumab trade name Xolair , Genentech Novartis is a humanized antibody approved for patients with moderate to severe or severe allergic asthma . Omalizumab s cost is high, ranging from 6000 24000 a year and hence omalizumab is mainly prescribed for patients ... . Like other protein and antibody drugs, omalizumab causes anaphylaxis a life threatening systemic allergic reaction in 1 to 2 patients per 1,000. ref NEJM 360 1002 ref Omalizumab is a recombinant ... use of omalizumab is for people with moderate to severe, persistent allergic asthma , uncontrollable with corticosteroids . ref name AFP05 cite journal last Davydov first L title Omalizumab ... to omalizumab, a reliable way to identify treatable patients has been a subject of considerable ... information on the long term effectiveness and side effects of the drug, omalizumab treatment ... effects The main adverse effects from omalizumab is anaphylaxis . ref name AFP05 There is a non significant trend to increases in the rate of cancer while taking omalizumab. The increased risk of cancer ... small increased risk of cancer in those taking omalizumab. Concerns have also been raised about ... pmid16990394 cite journal author Winchester DE, Jacob A, Murphy T title Omalizumab for asthma journal ... ref Mechanism of action Omalizumab inhibits the binding of IgE to the high affinity IgE receptor ... is critical to omalizumab s pharmacological effects because a typical anti IgE antibody can cross ... to which omalizumab binds is sterically hindered by the receptor when IgE is bound to the receptor and is therefore not accessible to omalizumab binding, preventing an inadvertent anaphylactic reaction. However, by binding to IgE in solution, omalizumab prevents IgE binding to cell surface receptor ... Fc RII is different from the sequence used to bind to Fc RI, omalizumab, by steric hindrance, also ... more details
|
- Tanox
for further development, because it had a better developed manufacturing process. Omalizumab, with the trade ... Omalizumab , trade name Xolair TNX 901 TNX 355 TNX 650 External links http www.tanox.com home ... more details
|
- List of drugs: X
List of drugs X X x X Trozine xa xe Xalatan xaliproden International Nonproprietary Name INN xamoterol International Nonproprietary Name INN Alprazolam Xanax xanomeline International Nonproprietary Name INN xanoxic acid International Nonproprietary Name INN xanthiol International Nonproprietary Name INN xantifibrate International Nonproprietary Name INN xantinol nicotinate International Nonproprietary Name INN xantocillin International Nonproprietary Name INN xantofyl palmitate International Nonproprietary Name INN Xatran Xeloda Xeloda Hoffmann La Roche Roche xemilofiban International Nonproprietary Name INN xenalipin International Nonproprietary Name INN xenazoic acid International Nonproprietary Name INN xenbucin International Nonproprietary Name INN Xeneisol Xenical xenipentone International Nonproprietary Name INN xenon 133 Xe International Nonproprietary Name INN xenthiorate International Nonproprietary Name INN xenygloxal International Nonproprietary Name INN xenyhexenic acid International Nonproprietary Name INN xenysalate International Nonproprietary Name INN xenytropium bromide International Nonproprietary Name INN xi xy xibenolol International Nonproprietary Name INN xibornol International Nonproprietary Name INN Xifaxan Xigris xilobam International Nonproprietary Name INN ximelagatran United States Adopted Name USAN ximoprofen International Nonproprietary Name INN xinidamine International Nonproprietary Name INN xinomiline International Nonproprietary Name INN xipamide International Nonproprietary Name INN xipranolol International Nonproprietary Name INN Xiral Omalizumab Xolair Xopenex xorphanol International Nonproprietary Name INN xylamidine tosilate International Nonproprietary Name INN xylazine International Nonproprietary Name INN Xylo Pfan Xylocaine Xylocard xylocoumarol International Nonproprietary Name INN xylofilcon A United States Adopted Name USAN xylometazoline International Nonproprietary Name INN xyloxemine International Nonproprietary Name ... more details
|
- Talizumab
Xolair omalizumab . Omalizumab is an anti IgE monoclonal antibody, which was placed in a development ... more details
|
- Respiratory Pharmacology
No lead date February 2012 List of drugs used in respiratory therapy There are several categories of respiratory drugs, each specific to a drug s purpose and mode of action. The following is a list of key pharmaceuticals in the prevention and treatment of respiratory related ailments. Adrenergic bronchodilator Adrenergic Sympathomimetic Bronchodilators Ultra Short Acting Epinephrine Racemic epinephrine Isoetarine Isoetharine Short Acting Orciprenaline Metaproterenol Salbutamol Albuterol Pirbuterol Levosalbutamol Levalbuterol ref cite book last Kester first edited by Robert L. Wilkins, James K. Stoller, Robert M. Kacmarek consulting editors, David C. Shelledy, Lucy title Egan s Fundamentals of Respiratory Care year 2009 publisher Mosby Elsevier location St. Louis, Mo. isbn 9780323036573 edition 9th ed. ref Long Acting Salmeterol Formoterol Arformoterol Anticholinergic Anticholinergic Parasympatholytic Bronchodilators Ipratropium bromide Tiotropium bromide Xanthine Xanthines Theophylline Choline theophyllinate Oxtriphylline Aminophylline Dyphylline Mucus controlling agents Acetylcysteine Acetylcysteine 10 ,20 Dornase alfa Saline medicine Hypertonic saline 3 10 Pulmonary surfactant Surfactants Pulmonary surfactant Beractant Pulmonary surfactant Calfactant Pulmonary surfactant Poractant alfa Corticosteroid Corticosteroids Beclometasone dipropionate Beclomethasone dipropionate Triamcinolone Triamcinolone acetonide Flunisolide Flunisolide hemihydrate Fluticasone Fluticasone propionate Budesonide Mometasone furoate ref cite book last Gardenhire first edited by Douglas S. title Rau s Respiratory Care Pharmacology. year 2008 publisher Mosby Elsevier location St. Louis, Mo. isbn 978 0 323 03202 5 edition 7th ed. ref Nonsteroidal Antiasthma agents Cromolyn like agents Cromoglicic acid Cromolyn sodium Nedocromil Nedocromil sodium Leukotriene antagonist Antileukotrienes Zafirlukast Montelukast Zileuton Monoclonal antibodies Monoclonal Antibody Omalizumab Aerosolized Antiinfectiv ... more details
|
- Allergic bronchopulmonary aspergillosis
of flare ups. There are also case reports of the use of omalizumab in the treatment of ABPA. ref Collins ... Treated Successfully with Omalizumab Three Case Reports. Oral presentation Annals of Allergy ... more details
|
- ATC code R03
Eprozinol R03DX03 Fenspiride R03DX05 Omalizumab R03DX06 Seratrodast R03DX07 Roflumilast References ... more details
|
- List of drugs: O-Op
USAN omadacycline United States Adopted Name USAN , International Nonproprietary Name INN omalizumab ... more details
|
- Bi-specific T-cell engager
the BiTE approach. ref cite journal title Conversion of cetuximab, panitumumab, trastuzumab and omalizumab ... more details
|
- Immunoglobulin E
would be beneficial. Of course, if this were the case, anti IgE treatments such as omalizumab for asthma ... of allergy drugs that seek to interfere with the IgE receptor interaction. A new treatment, omalizumab ... more details
|
- Genentech
Thrombolysis Clot busting drug to treat acute myocardial infarction . 2003 Omalizumab Xolair omalizumab Subcutaneous injection for moderate to severe persistent asthma . 2003 Efalizumab Raptiva ... more details
|
- Monoclonal antibody therapy
acute organ rejection rejection of kidney transplants. ref name Rang Omalizumab inhibits human ... Chronic lymphocytic leukemia Omalizumab Xolair 2004 humanized immunoglobulin E IgE mainly allergy related ... more details
|
- Aspergillus
. Bioresour Technol. 21 April 2008. Zirbes JM, Milla CE. Steroid Sparing effect of omalizumab for allergic ... more details
|
- Humanized antibody
Humanized antibodies are antibodies from non human species whose peptide sequence protein sequences have been modified to increase their similarity to antibody variants produced naturally in humans. ref name pmid3127726 cite journal author Riechmann L, Clark M, Waldmann H, Winter G title Reshaping human antibodies for therapy journal Nature volume 332 issue 6162 pages 332 323 year 1988 month pmid 3127726 doi 10.1038 332323a0 ref ref cite journal author Queen C, Schneider WP, Selick HE, Payne PW, Landolfi NF, Duncan JF, Avdalovic NM, Levitt M, Junghans RP, Waldmann TA. title A humanized antibody that binds to the interleukin 2 receptor. journal Proc Natl Acad Sci U S A. volume 86 issue 24 pages 10029 33 year 1989 month Dec pmid 2513570 doi 10.1073 pnas.86.24.10029 url pmc 298637 This is an early example of the use of the term humanized antibody . ref The process of humanization is usually applied to monoclonal antibody monoclonal antibodies developed for administration to humans for example, antibodies developed as anti cancer drugs . Humanization can be necessary when the process of developing a specific antibody involves antibody generator generation in a non human immune system such as that in mice . The protein sequences of antibodies produced in this way are partially distinct from homology biology homologous antibodies occurring naturally in humans, and are therefore potentially immunogenic when administered to human patients see also Human anti mouse antibody . Not all monoclonal antibodies designed for human administration need be humanized since many therapies are short term interventions see List of monoclonal antibodies to get an overview of the various types of antibodies developed for therapeutic administration in humans . The International Nonproprietary Name s of humanized antibodies end in zumab , as in omalizumab see Nomenclature of monoclonal antibodies . Humanized antibodies are distinct from chimeric antibodies . The latter also have their protein ... more details
|
- Cholinergic urticaria
. The anti IgE monoclonal antibody Omalizumab has been seen in some cases to cause symptom ... more details
|
- Annual pharmaceutical drug sales
AMD Genentech 875 815 380 omalizumab Xolair Asthma Genentech 517 472 425 320.6 187.6 25.1 somatropin ... more details
|
- Anaphylaxis
injection of the anti IgE antibody omalizumab is being studied as a method of preventing recurrence, but it is not yet recommended. ref name World11 ref cite journal last Vichyanond first P title Omalizumab ... more details
|
- Monoclonal antibodies
rejection rejection of kidney transplants. ref name Rang Omalizumab inhibits human immunoglobulin E ... T cells humanized omalizumab moderate to severe allergic asthma inhibits human immunoglobulin ... more details
|
- Han Chinese
IgE antibody Omalizumab for treatment of asthma was discovered and developed by ethnic Chinese scientists ... more details
|
- Food allergy
Infobox disease Name Food allergy Image Caption DiseasesDB ICD10 ICD10 T 78 0 t 66 ICD9 ICD9 V15.01 ICD9 V15.05 ICDO OMIM 147050 MedlinePlus 000817 eMedicineSubj med eMedicineTopic 806 MeshID D005512 A food allergy is an adverse Immune system immune response to a food protein. ref cite web url http www.foodallergy.org questions.html title Frequently Asked Questions publisher Food Allergy & Anaphylaxis Network ref ref cite web url http www.revolutionhealth.com conditions asthma allergies hay fever seasonal allergies introduction allergy glossary title Allergy Glossary of Terms publisher Revolution Health ref They are distinct from other adverse responses to food, such as food intolerance , pharmacological reactions, and toxin mediated reactions. The protein in the food is the most common allergy allergic component. These kinds of allergies occur when the body s immune system mistakenly identifies a protein as harmful. Some proteins or fragments of proteins are resistant to digestion and those that are not broken down in the digestive process are tagged by the Immunoglobulin E IgE . These tags fool the immune system into thinking that the protein is harmful. The immune system, thinking the organism the individual is under attack, triggers an allergic reaction. These reactions can range from mild to severe. Allergic responses include dermatitis , gastrointestinal and respiratory distress, including such life threatening Anaphylaxis anaphylactic responses as Anaphylaxis Biphasic anaphylaxis biphasic anaphylaxis and vasodilation these require immediate emergency intervention. Individuals with protein allergies commonly avoid contact with the problematic protein. Some medications may prevent, minimize or treat protein allergy reactions. Treatment consists of either immunotherapy desensitisation or avoidance, in which the allergic person avoids all forms of contact with the food to which they are allergic. Areas of research include anti IgE antibody omalizumab, or Xolair a ... more details
|
- List of monoclonal antibodies
PDGF R cancer Olokizumab ref name WHOList103 mab humanized Interleukin 6 IL6 ? Omalizumab ref name ... more details
|
- List of bestselling drugs
Xolair Omalizumab align right 429 align right 32 Hoffmann La Roche Roche , Genentech Asthma align right ... more details
|
- Allergy
inflammatory response. The first agent of this class is Omalizumab . While this form of immunotherapy ... more details
|